Atossa Therapeutics Financial Overview
Atossa Therapeutics's market cap is currently $92.24M. The company's EPS TTM is $-0.07; its P/E ratio is -3.00; Atossa Therapeutics is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-0.07. See an overview of income statement, balance sheet, and cash flow financials.
